Hookipa Pharma
AustriaWho owns Hookipa Pharma?
Hookipa Pharma is an Austrian Biotech company, now owned by Gilead Sciences, which acquired it in 2025 from Sofinnova Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2025 to Gilead Sciences.
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
2 ownership periods
Boehringer Ingelheim Venture Fund took Hookipa Pharma public via IPO in 2019 after 6 years.
Sofinnova Partners sold Hookipa Pharma to Gilead Sciences in 2025 after 6 years.
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
Switzerland
US
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Hookipa Pharma?
Hookipa Pharma is now owned by Gilead Sciences, which acquired it in 2025 from Sofinnova Partners.
When did Gilead Sciences acquire Hookipa Pharma?
Gilead Sciences acquired Hookipa Pharma in 2025, buying from Sofinnova Partners.
Who did Hookipa Pharma sell to?
Sofinnova Partners sold Hookipa Pharma to Gilead Sciences in 2025 (Trade Sale). Boehringer Ingelheim Venture Fund sold Hookipa Pharma to Sofinnova Partners in 2019 (IPO).
Who has owned Hookipa Pharma over time?
Hookipa Pharma has been through 2 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · 2013–2019 · sold to Sofinnova Partners · (IPO); Sofinnova Partners · via Sofinnova Capital IX · 2019–2025 · sold to Gilead Sciences · (Trade Sale).